Patterns and trends in continuous glucose monitoring utilization among commercially insured individuals with type 1 diabetes: 2010-2013 to 2016-2019
![Thumbnail](/xmlui/bitstream/handle/20.500.12511/12736/Ata%c3%a7-%c3%96mer-2024.pdf.jpg?sequence=4&isAllowed=y)
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2024Yazar
Lacy, Mary E.Lee, Katherine E.
Ataç, Ömer
Heier, Kory
Fowlkes, John
Kucharska Newton, Anna
Moga, Daniela C.
Üst veri
Tüm öğe kaydını gösterKünye
Lacy, M. E., Lee, K. E., Ataç, Ö., Heier, K., Fowlkes, J., Kucharska Newton, A. ... Moga, D. C. (2024). Patterns and trends in continuous glucose monitoring utilization among commercially insured individuals with type 1 diabetes: 2010-2013 to 2016-2019. Clinical Diabetes, 42(3), 388-397. http://dx.doi.org/10.2337/cd23-0051Özet
Prior studies suggest that only ∼30% of patients with type 1 diabetes use continuous glucose monitoring (CGM), but most studies to date focused on children and young adults seen by endocrinologists or in academic centers. This study examined national trends in CGM utilization among commercially insured children and adults with type 1 diabetes. Overall, CGM utilization was 20.12% in 2010-2013 and 49.78% in 2016-2019, reflecting a 2.5-fold increase in utilization within a period of <10 years. Identifying populations with low CGM use is a necessary first step in developing targeted interventions to increase CGM uptake.
Kaynak
Clinical DiabetesCilt
42Sayı
3Koleksiyonlar
- Makale Koleksiyonu [3790]
- Makale Koleksiyonu [358]
- PubMed İndeksli Yayınlar Koleksiyonu [4251]